Pfizer Statistics

Share Statistics

Pfizer has 5.69B shares outstanding. The number of shares has increased by 0.33% in one year.

Shares Outstanding	5.69B
Shares Change (YoY)	0.33%
Shares Change (QoQ)	0.25%
Owned by Institutions (%)	64.09%
Shares Floating	5.68B
Failed to Deliver (FTD) Shares	15,694
FTD / Avg. Volume	0.04%

Short Selling Information

The latest short interest is 99.27M, so 1.75% of the outstanding shares have been sold short.

Short Interest	99.27M
Short % of Shares Out	1.75%
Short % of Float	1.75%
Short Ratio (days to cover)	2.47

Valuation Ratios

The PE ratio is 18.74 and the forward PE ratio is 7.88. Pfizer's PEG ratio is 0.07.

PE Ratio	18.74
Forward PE	7.88
PS Ratio	2.36
Forward PS	2.2
PB Ratio	1.7
P/FCF Ratio	15.28
PEG Ratio	0.07

Financial Ratio History

Enterprise Valuation

Pfizer has an Enterprise Value (EV) of 212.87B.

EV / Sales	3.35
EV / EBITDA	11.74
EV / EBIT	16.7
EV / FCF	21.64

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.72.

Current Ratio	1.17
Quick Ratio	0.92
Debt / Equity	0.72
Debt / EBITDA	3.51
Debt / FCF	6.47
Interest Coverage	5.33

Financial Efficiency

Return on Equity is 9.09% and Return on Invested Capital is 9.33%.

Return on Equity	9.09%
Return on Assets	3.76%
Return on Invested Capital	9.33%
Revenue Per Employee	$785.52K
Profits Per Employee	$99.01K
Employee Count	81,000
Asset Turnover	0.3
Inventory Turnover	2.01

Taxes

Income Tax	-28M
Effective Tax Rate	-0.35%

Stock Price Statistics

The stock price has increased by -13.5% in the last 52 weeks. The beta is 0.44, so Pfizer's price volatility has been higher than the market average.

Beta	0.44
52-Week Price Change	-13.5%
50-Day Moving Average	24.39
200-Day Moving Average	25.18
Relative Strength Index (RSI)	52.04
Average Volume (20 Days)	42,462,974

Income Statement

In the last 12 months, Pfizer had revenue of 63.63B and earned 8.02B in profits. Earnings per share was 1.42.

Revenue	63.63B
Gross Profit	41.85B
Operating Income	16.48B
Net Income	8.02B
EBITDA	18.13B
EBIT	11.11B
Earnings Per Share (EPS)	1.42

Full Income Statement

Balance Sheet

The company has 1.04B in cash and 63.65B in debt, giving a net cash position of -62.61B.

Cash & Cash Equivalents	1.04B
Total Debt	63.65B
Net Cash	-62.61B
Retained Earnings	116.72B
Total Assets	206.09B
Working Capital	5.98B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.74B and capital expenditures -2.91B, giving a free cash flow of 9.84B.

Operating Cash Flow	12.74B
Capital Expenditures	-2.91B
Free Cash Flow	9.84B
FCF Per Share	1.74

Full Cash Flow Statement

Margins

Gross margin is 65.77%, with operating and profit margins of 25.91% and 12.6%.

Gross Margin	65.77%
Operating Margin	25.91%
Pretax Margin	12.61%
Profit Margin	12.6%
EBITDA Margin	28.49%
EBIT Margin	25.91%
FCF Margin	15.46%

Dividends & Yields

PFE pays an annual dividend of $2.13, which amounts to a dividend yield of 6.9%.

Dividend Per Share	$2.13
Dividend Yield	6.9%
Dividend Growth (YoY)	2.38%
Payout Ratio	112.7%
Earnings Yield	5.34%
FCF Yield	6.55%

Dividend Details

Analyst Forecast

The average price target for PFE is $26, which is 5.6% higher than the current price. The consensus rating is "Hold".

Price Target	$26
Price Target Difference	5.6%
Analyst Consensus	Hold
Analyst Count	10

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$7.09
Lynch Upside	-71.19%
Graham Number	22.27
Graham Upside	-9.51%

Stock Splits

The last stock split was on Nov 17, 2020. It was a forward split with a ratio of 527:500.

Last Split Date	Nov 17, 2020
Split Type	forward
Split Ratio	527:500

Scores

Altman Z-Score	2.12
Piotroski F-Score	7

Pfizer Inc. (PFE)